225 related articles for article (PubMed ID: 36399343)
1. Association of Pregnancy Characteristics and Maternal Mortality With Amniotic Fluid Embolism.
Mazza GR; Youssefzadeh AC; Klar M; Kunze M; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
JAMA Netw Open; 2022 Nov; 5(11):e2242842. PubMed ID: 36399343
[TBL] [Abstract][Full Text] [Related]
2. Trends, Characteristics, and Maternal Morbidity Associated With Unhoused Status in Pregnancy.
Green JM; Fabricant SP; Duval CJ; Panchal VR; Cahoon SS; Mandelbaum RS; Ouzounian JG; Wright JD; Matsuo K
JAMA Netw Open; 2023 Jul; 6(7):e2326352. PubMed ID: 37523185
[TBL] [Abstract][Full Text] [Related]
3. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
[TBL] [Abstract][Full Text] [Related]
4. The association between uterine adenomyosis and adverse obstetric outcomes: A propensity score-matched analysis.
Mandelbaum RS; Melville SJF; Violette CJ; Guner JZ; Doody KA; Matsuzaki S; Quinn MM; Ouzounian JG; Paulson RJ; Matsuo K
Acta Obstet Gynecol Scand; 2023 Jul; 102(7):833-842. PubMed ID: 37087741
[TBL] [Abstract][Full Text] [Related]
5. From appearance to essence: 10 years review of atypical amniotic fluid embolism.
Shen F; Wang L; Yang W; Chen Y
Arch Gynecol Obstet; 2016 Feb; 293(2):329-34. PubMed ID: 26092134
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and consequences of amniotic fluid embolism.
Kramer MS; Abenhaim H; Dahhou M; Rouleau J; Berg C
Paediatr Perinat Epidemiol; 2013 Sep; 27(5):436-41. PubMed ID: 23930779
[TBL] [Abstract][Full Text] [Related]
7. Assessment of placenta accreta spectrum at vaginal birth after cesarean delivery.
Matsuzaki S; Rau AR; Mandelbaum RS; Tavakoli A; Mazza GR; Ouzounian JG; Matsuo K
Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101115. PubMed ID: 37543142
[TBL] [Abstract][Full Text] [Related]
8. Severe placental abruption: clinical definition and associations with maternal complications.
Ananth CV; Lavery JA; Vintzileos AM; Skupski DW; Varner M; Saade G; Biggio J; Williams MA; Wapner RJ; Wright JD
Am J Obstet Gynecol; 2016 Feb; 214(2):272.e1-272.e9. PubMed ID: 26393335
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States.
Abenhaim HA; Azoulay L; Kramer MS; Leduc L
Am J Obstet Gynecol; 2008 Jul; 199(1):49.e1-8. PubMed ID: 18295171
[TBL] [Abstract][Full Text] [Related]
10. Risk factors, management, and outcomes of amniotic fluid embolism: A multicountry, population-based cohort and nested case-control study.
Fitzpatrick KE; van den Akker T; Bloemenkamp KWM; Deneux-Tharaux C; Kristufkova A; Li Z; Schaap TP; Sullivan EA; Tuffnell D; Knight M
PLoS Med; 2019 Nov; 16(11):e1002962. PubMed ID: 31714909
[TBL] [Abstract][Full Text] [Related]
11. Delivery risks and outcomes associated with grand multiparity.
Lee KE; Wen T; Faye AS; Huang Y; Hur C; Friedman AM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7708-7716. PubMed ID: 34470116
[TBL] [Abstract][Full Text] [Related]
12. Fatal amniotic fluid embolism: incidence, risk factors and influence on perinatal outcome.
Zhu C; Xu D; Luo Q
Arch Gynecol Obstet; 2023 Apr; 307(4):1187-1194. PubMed ID: 35397752
[TBL] [Abstract][Full Text] [Related]
13. Unsuspected placenta accreta spectrum at vaginal delivery: assessment of incidence, characteristics, and maternal morbidity.
Rau AR; Youssefzadeh AC; Matsuzaki S; Mandelbaum RS; Ouzounian JG; Matsuo K
Am J Obstet Gynecol MFM; 2023 May; 5(5):100805. PubMed ID: 36774226
[TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid embolism: an Australian-New Zealand population-based study.
McDonnell N; Knight M; Peek MJ; Ellwood D; Homer CS; McLintock C; Vaughan G; Pollock W; Li Z; Javid N; Sullivan E;
BMC Pregnancy Childbirth; 2015 Dec; 15():352. PubMed ID: 26703453
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid embolism: antepartum, intrapartum and demographic factors.
Fong A; Chau CT; Pan D; Ogunyemi DA
J Matern Fetal Neonatal Med; 2015 May; 28(7):793-8. PubMed ID: 24974876
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome.
Kramer MS; Rouleau J; Liu S; Bartholomew S; Joseph KS;
BJOG; 2012 Jun; 119(7):874-9. PubMed ID: 22530987
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the 4 diagnosis criteria proposed by the SMFM and the AFE foundation for amniotic fluid embolism in a monocentric population.
Ponzio-Klijanienko A; Vincent-Rohfritsch A; Girault A; Le Ray C; Goffinet F; Bonnet MP
J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101821. PubMed ID: 32474192
[TBL] [Abstract][Full Text] [Related]
18. Placental mesenchymal dysplasia complicated with sudden fetal demise and amniotic fluid embolism: a case report.
Wang SJ; Lin LL; Chen WC
BMC Pregnancy Childbirth; 2022 Dec; 22(1):927. PubMed ID: 36494789
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors, management and outcomes of amniotic-fluid embolism: a population-based cohort and nested case-control study.
Fitzpatrick KE; Tuffnell D; Kurinczuk JJ; Knight M
BJOG; 2016 Jan; 123(1):100-9. PubMed ID: 25683758
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid embolism: an evidence-based review.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2009 Nov; 201(5):445.e1-13. PubMed ID: 19879393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
